Zhang Jenny, Crossley Brian, Sun Alexander, Palchaudhuri Sonali, Pahwa Amit, O'Rourke Paul, Ahmed Nazeer, Pherson Emily
The Johns Hopkins Hospital, Baltimore, MD, USA.
Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.
Hosp Pharm. 2023 Apr;58(2):171-177. doi: 10.1177/00185787221123212. Epub 2022 Sep 29.
Acid suppression therapy (AST), including proton pump inhibitors and histamine 2 receptor antagonists, are an overused class of medications. When used inappropriately, AST leads to polypharmacy, increased healthcare costs, and possible negative health consequences.
To assess whether an intervention including prescriber education combined with a pharmacist-driven protocol was effective in reducing the percentage of patients who were discharged with inappropriate AST.
This was a prospective pre-post study of adult patients who were prescribed AST before or during their admission to an internal medicine teaching service. All internal medicine resident physicians received education on appropriate AST prescribing. During the 4-week intervention period, dedicated pharmacists assessed the appropriateness of AST and made recommendations regarding deprescribing if no appropriate indication was identified.
During the study period, there were 14 166 admissions during which patients were prescribed AST. Out of the 1143 admissions during the intervention period, appropriateness of AST was assessed by a pharmacist for 163 patients. AST was determined to be inappropriate for 52.8% (n = 86) of patients and discontinuation or de-escalate of therapy occurred in 79.1% (n = 68) of these cases. The percentage of patients discharged on AST decreased from 42.5% before the intervention to 39.9% after the intervention ( = .007).
This study suggests that a multimodal deprescribing intervention reduced prescriptions for AST without an appropriate indication at the time of discharge. To increase the efficiency of the pharmacist assessment several workflow improvements were identified. Further study is necessary to understand the long-term outcomes of this intervention.
抑酸疗法(AST),包括质子泵抑制剂和组胺2受体拮抗剂,是一类使用过度的药物。当使用不当时,AST会导致联合用药、医疗成本增加以及可能的负面健康后果。
评估一项包括开处方者教育和药剂师主导方案的干预措施是否能有效降低出院时接受不适当AST治疗的患者比例。
这是一项针对在内科教学服务机构入院前或入院期间接受AST治疗的成年患者的前瞻性前后对照研究。所有内科住院医师都接受了关于适当开具AST处方的教育。在为期4周的干预期内,专门的药剂师评估AST的适当性,并就是否停止用药提出建议,如果未发现适当的适应症。
在研究期间,共有14166例患者入院时接受了AST治疗。在干预期的1143例入院患者中,药剂师对163例患者的AST适当性进行了评估。结果发现,52.8%(n = 86)的患者AST使用不当,其中79.1%(n = 68)的患者停止用药或降低了治疗强度。出院时接受AST治疗的患者比例从干预前的42.5%降至干预后的39.9%(P = 0.007)。
本研究表明,多模式停药干预减少了出院时无适当适应症的AST处方。为提高药剂师评估的效率,确定了一些工作流程改进措施。有必要进一步研究以了解该干预措施的长期效果。